[GENP] YoY Annual (Unaudited) Result on 31-Dec-2012 [#4]

Stock
[GENP] GENTING PLANTATIONS BERHAD
Announcement Date
27-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
YoY- -26.01%
Quarter Report
Latest QR
Upcoming QR
GENP's Result
GENP's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,374,931 1,642,939 1,384,009 1,233,417 1,336,481 988,583 755,567 10.48%
PBT 247,429 519,786 300,325 403,838 601,342 439,739 301,934 -3.26%
Tax -70,834 -136,009 -80,462 -81,965 -158,664 -115,532 -63,964 1.71%
NP 176,595 383,777 219,863 321,873 442,678 324,207 237,970 -4.84%
-
NP to SH 189,749 377,245 227,797 327,063 442,031 324,210 235,661 -3.54%
-
Tax Rate 28.63% 26.17% 26.79% 20.30% 26.38% 26.27% 21.18% -
Total Cost 1,198,336 1,259,162 1,164,146 911,544 893,803 664,376 517,597 15.01%
-
Net Worth 4,176,182 3,869,571 3,429,854 3,422,399 3,232,707 2,866,028 2,544,411 8.60%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 42,614 76,473 362,335 94,855 123,313 94,776 68,153 -7.52%
Div Payout % 22.46% 20.27% 159.06% 29.00% 27.90% 29.23% 28.92% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 4,176,182 3,869,571 3,429,854 3,422,399 3,232,707 2,866,028 2,544,411 8.60%
NOSH 774,801 764,737 758,817 758,846 758,851 758,208 757,265 0.38%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 12.84% 23.36% 15.89% 26.10% 33.12% 32.80% 31.50% -
ROE 4.54% 9.75% 6.64% 9.56% 13.67% 11.31% 9.26% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 177.46 214.84 182.39 162.54 176.12 130.38 99.78 10.06%
EPS 24.49 49.33 30.02 43.10 58.25 42.76 31.12 -3.91%
DPS 5.50 10.00 47.75 12.50 16.25 12.50 9.00 -7.87%
NAPS 5.39 5.06 4.52 4.51 4.26 3.78 3.36 8.19%
Adjusted Per Share Value based on latest NOSH - 758,727
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 153.22 183.09 154.23 137.45 148.94 110.17 84.20 10.48%
EPS 21.15 42.04 25.39 36.45 49.26 36.13 26.26 -3.54%
DPS 4.75 8.52 40.38 10.57 13.74 10.56 7.59 -7.51%
NAPS 4.6539 4.3122 3.8222 3.8139 3.6025 3.1939 2.8354 8.60%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 10.60 10.00 11.04 9.00 8.60 8.80 6.24 -
P/RPS 5.97 4.65 6.05 5.54 4.88 6.75 6.25 -0.76%
P/EPS 43.28 20.27 36.78 20.88 14.76 20.58 20.05 13.67%
EY 2.31 4.93 2.72 4.79 6.77 4.86 4.99 -12.04%
DY 0.52 1.00 4.33 1.39 1.89 1.42 1.44 -15.60%
P/NAPS 1.97 1.98 2.44 2.00 2.02 2.33 1.86 0.96%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 22/02/16 25/02/15 26/02/14 27/02/13 27/02/12 22/02/11 24/02/10 -
Price 11.00 10.22 10.50 8.47 9.25 7.97 6.18 -
P/RPS 6.20 4.76 5.76 5.21 5.25 6.11 6.19 0.02%
P/EPS 44.92 20.72 34.98 19.65 15.88 18.64 19.86 14.56%
EY 2.23 4.83 2.86 5.09 6.30 5.37 5.04 -12.70%
DY 0.50 0.98 4.55 1.48 1.76 1.57 1.46 -16.34%
P/NAPS 2.04 2.02 2.32 1.88 2.17 2.11 1.84 1.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment